These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1698030)
1. The presence of a novel protein in calf serum that recognizes beta amyloid in the formalin-fixed section. Kanemaru K; Hasegawa M; Shimada H; Ihara Y Am J Pathol; 1990 Sep; 137(3):677-87. PubMed ID: 1698030 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer type dementia: diffuse type of senile plaques demonstrated by beta protein immunostaining. Yamaguchi H; Hirai S; Shoji M; Harigaya Y; Okamoto Y; Nakazato Y Prog Clin Biol Res; 1989; 317():467-74. PubMed ID: 2481323 [TBL] [Abstract][Full Text] [Related]
3. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Ikeda S; Allsop D; Glenner GG Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985 [TBL] [Abstract][Full Text] [Related]
4. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [TBL] [Abstract][Full Text] [Related]
5. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome. Ikeda S; Allsop D; Glenner GG Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370 [TBL] [Abstract][Full Text] [Related]
6. Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Murphy GM; Forno LS; Higgins L; Scardina JM; Eng LF; Cordell B Am J Pathol; 1994 May; 144(5):1082-8. PubMed ID: 8178931 [TBL] [Abstract][Full Text] [Related]
7. Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes. Dwork AJ; Liu D; Kaufman MA; Prohovnik I Clin Neuropathol; 1998; 17(1):45-9. PubMed ID: 9496540 [TBL] [Abstract][Full Text] [Related]
8. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
9. Gerstmann-Sträussler-Scheinker disease: immunohistological and experimental studies. Tateishi J; Kitamoto T; Hashiguchi H; Shii H Ann Neurol; 1988 Jul; 24(1):35-40. PubMed ID: 3046469 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774 [TBL] [Abstract][Full Text] [Related]
11. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Czasch S; Paul S; Baumgärtner W Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Westermark P; Shirahama T; Skinner M; Brun A; Cameron R; Cohen AS Lab Invest; 1982 May; 46(5):457-60. PubMed ID: 7043084 [TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibodies against amyloid-beta from healthy adults. Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434 [TBL] [Abstract][Full Text] [Related]
14. Immunoaffinity chromatographic purification of amyloid-related proteins from Alzheimer's disease brain tissue. Landon M; Smith MA; Clarke K; Kidd M Prog Clin Biol Res; 1989; 317():903-12. PubMed ID: 2574878 [TBL] [Abstract][Full Text] [Related]
15. Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody. Ikeda S; Wong CW; Allsop D; Landon M; Kidd M; Glenner GG Lab Invest; 1987 Oct; 57(4):446-9. PubMed ID: 3312810 [TBL] [Abstract][Full Text] [Related]
16. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain. Thal DR; Ghebremedhin E; Haass C; Schultz C Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Alzheimer's disease with commercially available anti-beta peptide (beta A4) antibodies following microwave oven pretreatment. Liberski PP; Kłoszewska I; Kordek R; Bratosiewicz J; Omulecka A; Papierz W; Alwasiak J Pol J Pathol; 1995; 46(1):43-6. PubMed ID: 7780697 [TBL] [Abstract][Full Text] [Related]
18. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Shoji M; Hirai S; Yamaguchi H; Harigaya Y; Ishiguro K; Matsubara E Am J Pathol; 1991 Jan; 138(1):247-57. PubMed ID: 1702930 [TBL] [Abstract][Full Text] [Related]
19. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Yamaguchi H; Nakazato Y; Hirai S; Shoji M; Harigaya Y Am J Pathol; 1989 Oct; 135(4):593-7. PubMed ID: 2679112 [TBL] [Abstract][Full Text] [Related]
20. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Weiner HL; Lemere CA; Maron R; Spooner ET; Grenfell TJ; Mori C; Issazadeh S; Hancock WW; Selkoe DJ Ann Neurol; 2000 Oct; 48(4):567-79. PubMed ID: 11026440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]